BRCA1, BRCA2 and your 23andMe raw data: what it can (and can't) tell you
If you've opened your 23andMe BRCA1 raw data looking for an answer about your cancer risk, this is the single most important thing to understand: 23andMe tests only a small, fixed handful of BRCA variants — far from all of them. An absent or "negative" result in your raw data is not a clinical all-clear, and it should never be read as reassurance. Here's what these genes are, what your file actually covers, and what to do instead.
Educational only. This article is for general information. It is not a medical diagnosis, not clinical advice, and not a substitute for clinical-grade genetic testing or genetic counseling. 23andMe raw data is not clinically validated for diagnosis.
What are BRCA1 and BRCA2?
BRCA1 and BRCA2 are genes that help repair damaged DNA. Everyone has two copies of each. When one copy carries a certain pathogenic (harmful) variant, that DNA-repair function is impaired, and the lifetime risk of hereditary breast and ovarian cancer rises substantially. BRCA variants are also linked to prostate, pancreatic, and other cancers. Because these variants are inherited, a finding in one family member can be relevant to relatives too.
This is exactly why people search their DNA data for BRCA markers — the stakes feel high, and they want an answer. But the format of consumer raw data makes that answer easy to misread.
How people look for BRCA markers in 23andMe raw data
After downloading their 23andMe raw data file, people open it and search for specific rsid rows tied to BRCA1 and BRCA2, then check the genotype letters at those positions. Some third-party tools do this automatically. On the surface it looks definitive — a marker is either present or absent. In reality, the picture is far narrower than it appears.
The critical limitation: 23andMe tests only a few BRCA variants
This is the heart of the matter. 23andMe's genotyping array reads specific, pre-selected positions — not the entire BRCA1 and BRCA2 genes. Historically, its BRCA-related testing has focused on just three founder mutations that are most common in people of Ashkenazi Jewish descent.
But there are thousands of other known pathogenic variants across BRCA1 and BRCA2 that 23andMe does not test for at all. If you carry one of those — and most pathogenic BRCA variants are not among the few that 23andMe checks — it simply will not appear in your raw data. The file can't show what it never measured.
A negative or absent BRCA result in 23andMe raw data is not an all-clear. It means the small set of variants 23andMe tests were not detected. It does not rule out the thousands of other pathogenic BRCA variants. Do not treat it as reassurance about your cancer risk.
Why this matters for your health decisions
The danger isn't the data itself — it's the false sense of safety a "negative" can create. Someone with a strong family history of breast or ovarian cancer could see no BRCA flag in their raw data, feel relieved, and skip the testing that would actually answer their question. That is precisely the outcome to avoid.
Consumer raw data is a useful window into well-studied markers, but for something as consequential as hereditary cancer risk, it is the wrong tool to rely on for a final answer.
What to do instead: clinical testing and genetic counseling
If you have a personal or family history of breast, ovarian, prostate, or pancreatic cancer — or you're simply concerned — the responsible path is clinical-grade BRCA testing ordered through a healthcare provider, paired with genetic counseling. Clinical testing sequences the BRCA genes far more comprehensively than a consumer array, and a genetic counselor can interpret the results in the context of your personal and family history and help you decide on next steps. Do not substitute 23andMe raw data for that process.
Can you still learn anything useful from your raw data?
Yes — with the right framing. Your raw file can show you which specific variants a consumer test did and didn't cover, alongside other well-studied health and trait markers, and it can be a helpful prompt to start a conversation with a clinician. The key is to treat it as a starting point and an educational tool, never as a diagnostic verdict. For the bigger picture of what raw data does and doesn't include, see our guide to 23andMe raw data.
Explore your raw DNA privately, on your device
Quanome imports your 23andMe, Ancestry, or whole-genome file and parses it locally on your phone — it's never uploaded to us. You can see which markers your file covers alongside your labs and Apple Health data, with an AI coach to put it in context. Quanome is for understanding and education and does not replace clinical-grade genetic testing or counseling. Learn more about Quanome →
Frequently asked questions
Does 23andMe test for all BRCA1 and BRCA2 variants?
No. 23andMe tests only a small, fixed set of BRCA variants — historically three founder mutations most common in people of Ashkenazi Jewish descent. Thousands of other pathogenic BRCA variants are not tested, so they will not appear in your raw data.
Is a negative 23andMe BRCA result reassuring?
No. A negative or absent BRCA result in your 23andMe raw data only means the few variants 23andMe checks were not detected. It does not rule out the thousands of other pathogenic BRCA variants and should not be treated as reassurance. If you are concerned, get clinical-grade testing and genetic counseling.
How should I actually find out my BRCA cancer risk?
Through clinical-grade BRCA testing ordered by a healthcare provider, combined with genetic counseling. This is far more comprehensive than consumer raw data and is interpreted alongside your personal and family history.
Get Quanome at launch
Interested in making sense of your DNA and health data privately? Join the waitlist for early access.